Movement Alert｜ASYMCHEM Rises 3.21% in Regular Trading, Technical Rebound After Prior Session Selloff Driven by Restricted Share Listing and Institutional Selling

On September 25, ASYMCHEM rose 3.21% in regular trading, trading at HKD 154.5/share, with turnover of HKD 11.25 million.

On the news front, the stock is staging a technical recovery following the prior session's 3.37% decline to HKD 152.0. That selloff was triggered by multiple converging factors: the listing of 1.2852 million A-share restricted shares under the company's stock incentive plan on September 24, Schroders PLC's disposal of 188,400 H-shares at an average price of approximately HKD 155.66 per share (reducing its stake from 11.53% to 10.85%), and recent successive sell-downs by JPMorgan (which cut its position to 7.82%) and executive Hong Liang (whose stake dropped to 1.81%). With profit-taking pressure largely absorbed, the stock exhibited a technical rebound.

ASYMCHEM is a pharmaceutical outsourcing company offering integrated CDMO services spanning small molecules, chemical macromolecules, biologics, formulations, and clinical research. Notably, the company's chemical macromolecule facility recently passed a U.S. FDA pre-approval inspection, and management has guided for full-year revenue growth of 19%-22%, supported by robust order momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)